French firm wins funds for work on HIV/AIDS, obesity

04/10/2013 | GenomeWeb Daily News (free registration)

Theradiag, an in vitro diagnostics and theranostics company based in France, will use $1.6 million from Oséo to design test kits as part of its collaborative effort with Splicos and the French National Center for Research and Science. The project, called CaReNA, is aimed at developing diagnostic tests and RNA-targeting therapeutics for obesity and HIV/AIDS.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC